With a massive investment of 2 billion dollars, Astrazeneca has plans to expand its manufacturing footprint in Maryland, USA. This includes a significant expansion of its flagship biologics manufacturing facility in Frederick and construction of a new state-of-the-art facility in Gaithersburg for the development and clinical supply of innovative molecules to be used in clinical trials.
Modern laboratory diagnostics is the first step toward successful patient treatment. During the MEDICA LABMED FORUM from November 17 to 20, experts will discuss what will shape laboratory medicine in the coming years.
Merck has entered into a definitive agreement to acquire the chromatography business of JSR Life Sciences. With this move, Merck has plans to expand its downstream processing portfolio.
Scientists have developed AI models that accurately identify children at high risk for sepsis within 48 hours. The technology can enable the kids to receive early preemptive care.
Researchers at the University of Pennsylvania have discovered a way to make mRNA vaccines safer and more effective — by adding anti-inflammatory molecules inspired by olive oil. Their new lipid design not only reduces side effects like soreness and fatigue but also boosts vaccine performance against diseases like Covid-19 and cancer.
Nitrate pollution threatens water, health, and ecosystems worldwide — but new research shows biochar could offer a low-cost, sustainable solution, turning agricultural and forestry waste into a powerful tool for cleaner soil and water.
A chemistry breakthrough has been achieved by chemists wherein they can make substitutes of the Tamoxifen drug which is used to prevent breast cancer in women and men. The new drug alternatives have the potential to be more effective and also have less side effects.
Using a wood burning stove at home can lead to a decline in lung function, according to research presented at the European Respiratory Society Congress in Amsterdam, the Netherlands.
Researchers have recently tested a Crispr/Cas9 gene-editing technique to help the immune system in a person’s body to fight advanced gastrointestinal cancers. The results have revealed promising signs of safety and potential effectiveness of the treatment.
Artificial intelligence and digitalisation: these two topics will also shape the next few years in laboratory diagnostics and laboratory medicine. During the four-day Labmed Forum at Medica 2024, the focus will be on how this will influence diagnoses and therapies.